2 citations · 2 across the 1 of their papers we have counts for
1 paper
Alexandra Erdmann, Jan Beyersmann, Kaspar Rufibach
When planning an oncology clinical trial, the usual approach is to assume proportional hazards and even an exponential distribution for time-to-event endpoints. Often, besides the…